Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Agile Therapeutics Inc. AGRX

Alternate Symbol(s):  AGXRW

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.


Recent & Breaking News (NDAQ:AGRX)

AGILE (AGRX) ALERT: Johnson & Weaver, LLP Announces Filing of Class Action Complaint Against Agile Therapeutics, Inc.; Encourages all Investors to Contact the Firm for Information

PR Newswire January 10, 2017

Harwood Feffer LLP Announces Investigation of Agile Therapeutics, Inc.

PR Newswire January 9, 2017

AGILE NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Agile Therapeutics, Inc. To Contact The Firm

PR Newswire January 9, 2017

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Agile Therapeutics, Inc. – AGRX

Business Wire January 9, 2017

IMPORTANT AGILE THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP notifies investors that a securities class action lawsuit has been filed on behalf of shareholders of Agile Therapeutics, Inc. in the District of New Jersey -- AG

GlobeNewswire January 9, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017

PR Newswire January 9, 2017

Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against Agile Therapeutics, Inc.

Business Wire January 6, 2017

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Agile Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm

Business Wire January 5, 2017

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Agile Therapeutics, Inc. Investors

Business Wire January 5, 2017

INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Agile Therapeutics, Inc. Investors

Business Wire January 4, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Agile Therapeutics, Inc. (AGRX)

PR Newswire January 4, 2017

Mid-Afternoon Market Update: NASDAQ Gains Over 50 Points; Evoke Pharma Shares Spike Higher

Benzinga.com  January 4, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agile Therapeutics, Inc. - AGRX

PR Newswire January 4, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal Securities Laws by Certain Officers and Directors of Agile Therapeutics, Inc.

Business Wire January 4, 2017

Mid-Morning Market Update: Markets Open Higher; UniFirst Posts Lower Q1 Profit

Benzinga.com  January 4, 2017

15 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  January 4, 2017

Agile Therapeutics Announces Positive Top-line Phase 3 Results

GlobeNewswire January 3, 2017

Agile Therapeutics to Present at Biotech Showcase 2017

GlobeNewswire December 22, 2016

Agile Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 22, 2016

Agile Therapeutics Receives Approximately $3 Million in Non-Dilutive Funding from New Jersey’s Technology Business Tax Certificate Transfer Program

GlobeNewswire December 1, 2016